Stocks and Investing Stocks and Investing
Wed, November 22, 2023
Tue, November 21, 2023
Mon, November 20, 2023

Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $3 on, Nov 20th, 2023


Published on 2024-10-28 07:40:53 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Decreased Target from $12 to $3 on, Nov 20th, 2023.

Robert has made no other calls on ADCT in the last 4 months.



There are 3 other peers that have a rating on ADCT. Out of the 3 peers that are also analyzing ADCT, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Boris Peaker of "TD Cowen" Downgraded from Buy to Hold on, Thursday, November 9th, 2023
  • Brian Cheng of "JP Morgan" Upgraded from Sell to Hold on, Thursday, August 10th, 2023


This is the rating of the analyst that currently disagrees with Robert


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $6 on, Wednesday, November 8th, 2023